Redefining injectable PMMA bone cement: Beta-tricalcium phosphate integration for bioactive and osteoconductive performance for minimally invasive applications

Background: Poly(methyl methacrylate) (PMMA) is commonly used as injectable bone cement; however, its exothermic polymerization, excessive stiffness, and bioinertness limit its clinical performance. To address these drawbacks, various types of PMMA-based bone cements modified with ceramic components have been developed. Objective: We refined a PMMA-based bone cement with a high substitution of beta-tricalcium phosphate (β-TCP) for minimally invasive applications. Methods: Composite cements with various weight ratios of β-TCP were in vitro characterized for the injectability, curing profile, radiopacity, weight change, compressive strength, and cytocompatibility. Osteoblast-like MG-63 cells were utilized for the biological assessments. For the in vivo evaluation, the composites were injected into the distal femora of rabbits, followed by micro-computed tomography (μ-CT) and histological analyses conducted after 24 weeks. Results: Incorporation of β-TCP significantly lowered the maximum curing temperature and extended the setting time, while good injectability was still maintained. As the β-TCP content increased, both radiopacity and compressive strength increased proportionally with minor weight changes after immersion in simulated body fluid. Cytocompatibility assays demonstrated a reduction in lactate dehydrogenase release with β-TCP substitution, accompanied by improved cell viability. In vivo studies using μ-CT and histology demonstrated improved bone-cement adaptation, direct contact with host bone, and deposition of new bone matrix without the formation of fibrous tissue. Conclusion: β-TCP substitution enhanced the handling, radiological, mechanical, and biological properties of PMMA cement, enabling partial osteointegration at the bone-cement interface. The findings suggest that this injectable PMMA/β-TCP composite can be delivered through a biopsy needle and holds promise for minimally invasive applications such as vertebroplasty, kyphoplasty, and defect filling.

Authors

Institutions

Publication Details

Journal
Bio-Medical Materials and Engineering
Published
2026-11-13
DOI
https://doi.org/10.1177/09592989261487245
Primary Topic
Bone Tissue Engineering Materials
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Redefining injectable PMMA bone cement: Beta-tricalcium phosphate integration for bioactive and osteoconductive performance for minimally invasive applications

Kai‐Chiang Yang, Chih‐Yung Chiang, Ling Yeh, Chang-Chin Wu
1 links
Bio-Medical Materials and Engineering
Bone Tissue Engineering Materials
article

Redefining injectable PMMA bone cement: Beta-tricalcium phosphate integration for bioactive and osteoconductive performance for minimally invasive applications

Kai‐Chiang Yang, Chih‐Yung Chiang, Ling Yeh, Chang-Chin Wu
article en

Abstract

Background: Poly(methyl methacrylate) (PMMA) is commonly used as injectable bone cement; however, its exothermic polymerization, excessive stiffness, and bioinertness limit its clinical performance. To address these drawbacks, various types of PMMA-based bone cements modified with ceramic components have been developed. Objective: We refined a PMMA-based bone cement with a high substitution of beta-tricalcium phosphate (β-TCP) for minimally invasive applications. Methods: Composite cements with various weight ratios of β-TCP were in vitro characterized for the injectability, curing profile, radiopacity, weight change, compressive strength, and cytocompatibility. Osteoblast-like MG-63 cells were utilized for the biological assessments. For the in vivo evaluation, the composites were injected into the distal femora of rabbits, followed by micro-computed tomography (μ-CT) and histological analyses conducted after 24 weeks. Results: Incorporation of β-TCP significantly lowered the maximum curing temperature and extended the setting time, while good injectability was still maintained. As the β-TCP content increased, both radiopacity and compressive strength increased proportionally with minor weight changes after immersion in simulated body fluid. Cytocompatibility assays demonstrated a reduction in lactate dehydrogenase release with β-TCP substitution, accompanied by improved cell viability. In vivo studies using μ-CT and histology demonstrated improved bone-cement adaptation, direct contact with host bone, and deposition of new bone matrix without the formation of fibrous tissue. Conclusion: β-TCP substitution enhanced the handling, radiological, mechanical, and biological properties of PMMA cement, enabling partial osteointegration at the bone-cement interface. The findings suggest that this injectable PMMA/β-TCP composite can be delivered through a biopsy needle and holds promise for minimally invasive applications such as vertebroplasty, kyphoplasty, and defect filling.

Bio-Medical Materials and Engineering
Universitas Airlangga (ID), Taipei Medical University Hospital (TW), En Chu Kong Hospital (TW), Taipei Medical University (TW)
Ministry of Science and Technology, Taiwan
Good health and well-being
Bone Tissue Engineering Materials
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon